Skip to main content

Login to North West London Pathology – consumables service

If you need a new account or you have a query about your order, please telephone the pathology call centre on 0203 313 5353.

If you have forgotten your password you can reset this yourself. Please click here if you have forgotten your password.

Results Line and Enquiries

0203 313 5353

Collagen Binding Assay (VWF)

Category Haematology >> Specialised Coagulation Services
Test background

Collagen Binding Assay (CBA) is a second line test in the investigation of von Willebrand disease in order to provide further information where the disease subtype is unclear or where a collagen binding defect is suspected. CBA is performed as a semi-automated ELISA using manufactured microtitre plates coated with collagen type III.

The collagen binding capacity of vWF should normally be comparable to VWF concentration in plasma (vWF antigen) and also VWF function as assessed by the ristocetin cofactor activity assay. However, occasionally, collagen binding functionality is reduced. Results should be interpreted with VWF Antigen, VWF Ristocetin cofactor activity and Factor VIII level.

Clinical Indications

CBA is particularly informative when attempting to distinguish between various VWD subtypes or where collagen binding defects are suspected due to family history.

Reference range

0.45 – 1.50 IU/mL

Sample & container required 4.5 mL sodium citrate (pale blue top) adults 1.8 mL sodium citrate (pale blue top) paediatrics
Turnaround time 14 days

All requests must be discussed with and approved by the haematology clinical team.

Please Note: Samples will be rejected if under/over-filled, clotted or haemolysed